Today: 8 May 2026
NuScale slides again as dilution worries shadow small-reactor stocks
29 December 2025
1 min read

NuScale slides again as dilution worries shadow small-reactor stocks

NEW YORK, December 29, 2025, 13:58 ET — Regular session

  • NuScale shares fell about 2.6% in afternoon trading, lagging the broader market
  • Peers Oklo and Nano Nuclear also declined, extending a late-year pullback in SMR developers
  • Investors are focused on funding risk after NuScale’s recent authorized-share increase

NuScale Power Corp shares fell about 2.6% on Monday, extending a late-year slide in high-volatility nuclear-reactor developers. The stock was down 2.6% at $14.46 in afternoon trading.

NuScale and its peers have become a fast-moving proxy for sentiment on small modular reactors, or SMRs — smaller nuclear units designed to be factory-built and deployed in clusters to generate power. Bulls argue SMRs could help meet growing electricity demand, including from data centers, while skeptics point to long timelines and uncertain costs.

That debate has sharpened into a near-term question for equity investors: funding. In a Form 8-K filed on Dec. 17, NuScale said shareholders approved an amendment increasing authorized Class A common stock to 662 million shares from 332 million — a step that can give a company more flexibility to issue stock and raise cash.

There was no immediately apparent company catalyst for Monday’s move. NuScale was among the most active stocks in premarket trading, Nasdaq data showed.

Other U.S.-listed SMR developers moved lower as well, with Oklo down about 3.5% and Nano Nuclear Energy off roughly 7.7%.

Centrus Energy, a supplier tied to the nuclear fuel cycle, fell about 1.9%.

The broader market also dipped, with the SPDR S&P 500 ETF down about 0.4%, leaving NuScale’s decline to stand out in a quiet session.

NuScale has also been navigating shareholder overhang after Fluor Corp and NuScale said in November they reached an agreement on the conversion and monetization of Fluor’s remaining stake.

For traders, the near-term setup is straightforward: any hint of equity issuance can pressure the stock, while fresh customer or partner commitments can reverse sentiment quickly. With SMR projects measured in years, the market has tended to react most sharply to financing signals.

NuScale remains the only U.S. company with an NRC-approved SMR design, Reuters has reported. “We now have an American technology that is near-term deployable,” CEO John Hopkins said when regulators approved the company’s uprated 77-megawatt design in May. Reuters

The company has signed deals to deploy reactors in Romania and Poland, Reuters reported in November, as U.S. small-reactor developers push overseas while they seek firm orders at home.

In the United States, ENTRA1 Energy signed an agreement to develop facilities powered by NuScale technology that could supply up to 6 gigawatts to the Tennessee Valley Authority under proposed power purchase agreements, Reuters reported.

Next up, investors are likely to watch for any capital-raising steps or additional filings tied to the expanded share authorization, as well as updates on commercial timelines and partner execution. Market calendars such as Zacks expect NuScale’s next earnings release around March 2, 2026, keeping attention on cash use and any guidance for 2026.

Stock Market Today

  • CrowdStrike Shares Surpass $408.56 Analyst Target Amid Mixed Ratings
    May 8, 2026, 7:41 AM EDT. Shares of CrowdStrike Holdings Inc (CRWD) climbed to $414.05, surpassing the average 12-month analyst target price of $408.56. This target reflects the combined expectations of 43 analysts, whose individual price forecasts vary widely, from $185 to $475. With 34 analysts currently rating CRWD as a "strong buy" and only one issuer a "strong sell," the consensus leans bullish but shows some caution. Analysts may revise their targets upward or downward based on recent gains and company fundamentals. Investors are advised to reassess CrowdStrike's valuation as its stock price exceeds the crowd-sourced benchmark, presenting potential either for further growth or profit-taking.

Latest article

Zoetis Stock Plunge: The Pet-Care Slowdown Wall Street Can’t Ignore

Zoetis Stock Plunge: The Pet-Care Slowdown Wall Street Can’t Ignore

8 May 2026
Zoetis cut its 2026 revenue forecast to $9.68 billion-$9.96 billion and lowered adjusted EPS guidance after U.S. companion-animal product sales dropped 11% in the first quarter. Shares fell $23.86 to $87.31. First-quarter adjusted EPS came in at $1.53, missing analyst estimates of $1.61. CEO Kristin Peck cited weaker demand, fewer vet visits, and increased competition.
Gas Prices May Stay High Even After an Iran Peace Deal — Here’s Why

Gas Prices May Stay High Even After an Iran Peace Deal — Here’s Why

8 May 2026
U.S. regular gasoline averaged $4.546 a gallon Friday, near its highest since 2022, according to AAA. Prices remain elevated as fighting near the Strait of Hormuz disrupts oil flows, despite signs of progress toward a U.S.-Iran deal. Analysts say pump prices are unlikely to return to pre-war levels before 2027. Oil benchmarks hovered near $100 a barrel, with inventories still low.
Planet Fitness Stock Just Had Its Worst Day — Weak Sign-Ups Forced a 2026 Reset

Planet Fitness Stock Just Had Its Worst Day — Weak Sign-Ups Forced a 2026 Reset

8 May 2026
Planet Fitness shares plunged 31% to $44.01 Thursday after the company cut its 2026 growth targets and paused a planned Black Card price hike. The company now expects about 1% same-club sales growth and 7% revenue growth for 2026, down from earlier forecasts. First-quarter revenue rose 21.9% to $337.2 million, but management cited weak member growth and increased competition.
Pfizer filings spotlight big portfolio shifts as Live Oak slashes stake 92%
Previous Story

Pfizer filings spotlight big portfolio shifts as Live Oak slashes stake 92%

Sibanye Stillwater drops as gold, platinum retreat from record highs
Next Story

Sibanye Stillwater drops as gold, platinum retreat from record highs

Go toTop